GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Accumulated other comprehensive income (loss)

Cinclus Pharma Holding AB (OSTO:CINPHA) Accumulated other comprehensive income (loss) : kr0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Cinclus Pharma Holding AB's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2024 was kr0.00 Mil.

Cinclus Pharma Holding AB Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Cinclus Pharma Holding AB's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB Accumulated other comprehensive income (loss) Chart

Cinclus Pharma Holding AB Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
- - - -

Cinclus Pharma Holding AB Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cinclus Pharma Holding AB Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Cinclus Pharma Holding AB Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Cinclus Pharma Holding AB's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cinclus Pharma Holding AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
OSTO:ORX OSTO:DICOT OSTO:MOB OSTO:ENZY OSTO:KLAR OSTO:NANEXA XSAT:ACUC OSTO:ERMA OSTO:VIVE OSTO:TOL ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
Kungsbron 1, Stockholm, SWE, SE-111 22
Website
https://www.cincluspharma.com
Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines